Farms.com Home   News

Emergency order from Delaware's Nutrient Management Commission allows fall staging of poultry litter

Emergency order from Delaware's Nutrient Management Commission allows fall staging of poultry litter

By Kelli Steele

An emergency order issued by Delaware’s Nutrient Management Commission allows for the fall staging of poultry litter next month.

The order creates a 180-day extension for properly staged poultry litter in Delaware crop fields beginning November 1, 2022, allowing farmers to stage litter in the fields where it will be used to fertilize next spring.

“The take home message here is - as a result of the increased risk of high path (pathogenic) avian influenza (HPAI), the Commission is searching for a way to give farmers flexibility to take poultry litter that has a great commodity value to help grow their crops and put it in the field(s) until spring,” said Chris Brosch, administrator for Delaware’s Nutrient Management Program.

He says control orders issued last spring by Delaware’s Department of Agriculture severely restricted the movement and spreading of poultry litter because of an outbreak of avian flu in Kent and New Castle Counties.

Brosch says that caused some farmers hardship. This new order is meant to not only to help them, but also prevent further spread of avian flu - most recently detected in two backyard flocks in Kent County.

Properly staged litter must be stacked in six-foot tall pyramids and once the 180-day extension expires, the normal 90-day regulation will resume.

Brosch says there’s a proper method to properly stage litter.

Click here to see more...

Trending Video

New discovery may lead to better vaccines for pork producers

Video: New discovery may lead to better vaccines for pork producers



Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe disease in pigs, leading to significant economic losses for pork producers across the globe. It’s estimated that PRRS costs the Canadian pork industry $130M annually. Using the CMCF beamline, researchers from the University of Manitoba and the Leiden University Medical Centre (Netherlands) were able to see the structure of the PRRSV protease, a type of protein the pathogen uses to suppress a host’s immune system. The vital information they uncovered can be used to develop new vaccines against PRRSV and also helps inform development of vaccines against emerging human viruses.